{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T05:23:08Z","timestamp":1772601788840,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.seizure.2015.07.018","type":"journal-article","created":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T22:01:57Z","timestamp":1438293717000},"page":"149-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy"],"prefix":"10.1016","volume":"31","author":[{"given":"Annika","family":"Sattler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodor W.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.seizure.2015.07.018_bib0005","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2165\/00003088-200342120-00002","article-title":"Clinical pharmacokinetics of oxcarbazepine","volume":"42","author":"May","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.seizure.2015.07.018_bib0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.seizure.2007.12.003","article-title":"Central nervous system adverse effects of new antiepileptic drugs. A meta-analysis of placebo-controlled studies","volume":"17","author":"Zaccara","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2015.07.018_bib0015","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.57.5.864","article-title":"Oxcarbazepine (Trileptal\u00ae) as monotherapy in patients with partial seizures","volume":"57","author":"Sachdeo","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2015.07.018_bib0020","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0896-6974(98)00041-3","article-title":"Oxcarbazepine in treatment of childhood epilepsy: a survey of 46 children and adolescents","volume":"11","author":"Borusiak","year":"1998","journal-title":"J Epilepsy"},{"key":"10.1016\/j.seizure.2015.07.018_bib0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s001150050419","article-title":"Therapiekommisson der Deutschen Sektion der Internationalen Liga gegen Epilepsie. Serumkonzentration von Antiepileptika Praktische Richtlinien zur Messung und sinnvollen Interpretation","volume":"70","author":"Fr\u00f6scher","year":"1999","journal-title":"Nervenarzt"},{"issue":"2","key":"10.1016\/j.seizure.2015.07.018_bib0030","first-page":"97","article-title":"Oxcarbazepine and adverse events: impact of age, dosage, metabolite serum concentrations and concomitant antiepileptic therapy","volume":"23","author":"Ortenzi","year":"2008","journal-title":"Funct Neurol"},{"key":"10.1016\/j.seizure.2015.07.018_bib0035","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/00007691-200202000-00013","article-title":"Marketed new antiepielptic drugs: are they better than old-generation agents?","volume":"24","author":"Perucca","year":"2002","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.seizure.2015.07.018_bib0040","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.eplepsyres.2006.01.011","article-title":"Relationship between serum mono-hydroxy-carbazepine concentrations and adverse effects in patients with epilepsy on high-dose oxcarbazepine therapy","volume":"59","author":"Striano","year":"2006","journal-title":"Epilepsy Res"},{"issue":"10","key":"10.1016\/j.seizure.2015.07.018_bib0045","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s002280050001","article-title":"Therapeutic monitoring of the new antiepileptic drugs","volume":"55","author":"Tomson","year":"2000","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.07.018_bib0050","series-title":"Methods and applications","article-title":"Regression: models","author":"Fahrmeir","year":"2013"},{"issue":"12","key":"10.1016\/j.seizure.2015.07.018_bib0055","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/j.1499-1654.2000.001597.x","article-title":"Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy","volume":"41","author":"Barcs","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.07.018_bib0060","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/ane.12207","article-title":"Efficacy and safety of extended-release oxcarbazepine (Oxtellar XR\u2122) as adjunctive therapy in patients with refractory partial-onset seizures: a randomized controlled trial","volume":"129","author":"French","year":"2014","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2015.07.018_bib0065","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.yebeh.2006.04.022","article-title":"Efficacy, safety and tolerability of oxcarbazepine monotherapy","volume":"9","author":"Martinez","year":"2006","journal-title":"Epilepsy Behav"},{"issue":"12","key":"10.1016\/j.seizure.2015.07.018_bib0070","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1212\/WNL.54.12.2245","article-title":"Oxcarbazepine monotherapy for partial-onset seizures: A multicenter, double-blind, clinical trial","volume":"54","author":"Beydoun","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.seizure.2015.07.018_bib0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.yebeh.2005.07.017","article-title":"Long-term safety and tolerability of oxcarbazepine in children: A review of clinical experience","volume":"7","author":"Bourgeois","year":"2005","journal-title":"Epilepsy Behav"},{"issue":"5","key":"10.1016\/j.seizure.2015.07.018_bib0080","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1528-1167.2009.02489.x","article-title":"Safety profile of oxcarbazepine: results from a prescription-event-monitoring study","volume":"51","author":"Buggy","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.07.018_bib0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.seizure.2013.03.016","article-title":"Neurological adverse events of new generation sodium blocker antiepileptic drugs Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine","volume":"22","author":"Zaccara","year":"2013","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.seizure.2015.07.018_bib0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/epi.12043","article-title":"Extended-release antiepileptic drugs: a comparison of pharmacokinetic parameters relative to original immediate-release formulations","volume":"54","author":"Leppik","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2015.07.018_bib0095","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.eplepsyres.2009.09.013","article-title":"Short-term impact of the switch from immediate-release to extended-release oxcarbazepine in epilepsy patients on high dosages","volume":"87","author":"Steinhoff","year":"2009","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2015.07.018_bib0100","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00115-012-3598-2","article-title":"Retardiertes vs. schnell freisetzendes Oxcarbazepin bei therapierefrakt\u00e4rer fokaler Epilepsie Eine offene multizentrische, randomisierte kontrollierte Studie","volume":"10","author":"Steinhoff","year":"2012","journal-title":"Nervenarzt"},{"issue":"6","key":"10.1016\/j.seizure.2015.07.018_bib0105","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.1600-0404.1996.tb00016.x","article-title":"Fluctuations of 10-hydroxy-carbazepine during the day in epileptic patients","volume":"93","author":"May","year":"1996","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.seizure.2015.07.018_bib0110","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/17512433.2.2.155","article-title":"Oxcarbazepine extended-release formulation in epilepsy","volume":"2","author":"Steinhoff","year":"2009","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.07.018_bib0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pediatrneurol.2006.02.009","article-title":"Oxcarbazepine monotherapy in children and adolescents: a single-center clinical experience","volume":"35","author":"Kothare","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2015.07.018_bib0120","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1177\/0091270004266617","article-title":"Oxcarbazepine pharmacokinetics and tolerability in children with inadequately controlled epilepsy","volume":"44","author":"Rey","year":"2004","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2015.07.018_bib0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1525-5050(03)00037-4","article-title":"Safety and tolerability of oxcarbazepine in elderly patients with epilepsy","volume":"4","author":"Kutluay","year":"2003","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.seizure.2015.07.018_bib0130","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/clpt.1991.158","article-title":"The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepine","volume":"50","author":"van Heiningen","year":"1991","journal-title":"Clin Pharmacol Ther"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131115001910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131115001910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:46:40Z","timestamp":1761011200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131115001910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":26,"alternative-id":["S1059131115001910"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2015.07.018","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between mono-hydroxy-carbazepine serum concentrations and adverse effects in patients on oxcarbazepine monotherapy","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2015.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}